Cullinan Associates’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$32.6M Sell
225,713
-33,337
-13% -$5.05M 2.64% 8
2025
Q4
$37.1M Sell
259,050
-3,100
-1% -$457K 2.52% 9
2025
Q3
$40.3M Sell
262,150
-242
-0.1% -$37.8K 2.62% 7
2025
Q2
$41.8M Sell
262,392
-272
-0.1% -$44.4K 2.76% 7
2025
Q1
$44.8M Buy
262,664
+650
+0.2% +$109K 3.16% 7
2024
Q4
$43.9M Sell
262,014
-19,543
-7% -$3.33M 2.82% 7
2024
Q3
$47.8M Sell
281,557
-11,871
-4% -$2.02M 2.69% 7
2024
Q2
$48.4M Sell
293,428
-10,619
-3% -$1.74M 2.74% 7
2024
Q1
$49.3M Sell
304,047
-616
-0.2% -$96.6K 2.77% 8
2023
Q4
$44.6M Sell
304,663
-13,144
-4% -$1.95M 2.49% 9
2023
Q3
$46.4M Buy
317,807
+1,164
+0.4% +$178K 2.7% 7
2023
Q2
$48M Buy
316,643
+1,230
+0.4% +$185K 2.64% 6
2023
Q1
$46.9M Buy
315,413
+16,262
+5% +$2.32M 2.74% 6
2022
Q4
$45.3M Sell
299,151
-176
-0.1% -$24.7K 2.51% 7
2022
Q3
$37.8M Buy
299,327
+9,175
+3% +$1.3M 2.39% 7
2022
Q2
$41.7M Buy
290,152
+426
+0.1% +$64K 2.55% 7
2022
Q1
$44.3M Sell
289,726
-12,126
-4% -$1.9M 2.32% 7
2021
Q4
$49.4M Buy
301,852
+2,637
+0.9% +$392K 2.51% 6
2021
Q3
$41.8M Buy
299,215
+7,533
+3% +$1.07M 2.31% 6
2021
Q2
$39.4M Buy
291,682
+36,889
+14% +$4.99M 2.2% 7
2021
Q1
$34.5M Buy
254,793
+2,482
+1% +$324K 1.99% 7
2020
Q4
$35.1M Sell
252,311
-12,252
-5% -$1.71M 2.11% 7
2020
Q3
$36.8M Buy
264,563
+40,246
+18% +$5.34M 2.37% 6
2020
Q2
$26.8M Sell
224,317
-6,816
-3% -$795K 1.88% 8
2020
Q1
$25.4M Buy
231,133
+70,458
+44% +$8.46M 2.08% 6
2019
Q4
$20.1M Sell
160,675
-3,665
-2% -$448K 1.34% 12
2019
Q3
$20.4M Sell
164,340
-4,227
-3% -$499K 1.46% 7
2019
Q2
$18.5M Buy
168,567
+7,218
+4% +$769K 1.34% 10
2019
Q1
$16.8M Buy
161,349
+12,118
+8% +$1.18M 1.26% 13
2018
Q4
$13.7M Sell
149,231
-13,560
-8% -$1.21M 1.13% 15
2018
Q3
$13.5M Sell
162,791
-10,400
-6% -$851K 0.98% 18
2018
Q2
$13.5M Sell
173,191
-4,650
-3% -$350K 1.03% 17
2018
Q1
$14.1M Sell
177,841
-37,278
-17% -$3.11M 1.07% 18
2017
Q4
$19.8M Sell
215,119
-81,025
-27% -$7.29M 1.45% 8
2017
Q3
$26.9M Sell
296,144
-21,059
-7% -$1.92M 2.08% 6
2017
Q2
$27.6M Sell
317,203
-17,015
-5% -$1.5M 2.15% 6
2017
Q1
$30M Buy
334,218
+3,959
+1% +$351K 2.45% 4
2016
Q4
$27.8M Sell
330,259
-18,908
-5% -$1.61M 2.37% 4
2016
Q3
$31.3M Sell
349,167
-567
-0.2% -$49.2K 2.68% 3
2016
Q2
$29.6M Sell
349,734
-3,941
-1% -$323K 2.41% 5
2016
Q1
$29.1M Buy
353,675
+2,823
+0.8% +$227K 2.49% 5
2015
Q4
$27.9M Sell
350,852
-49,617
-12% -$3.79M 2.43% 5
2015
Q3
$28.8M Sell
400,469
-79,291
-17% -$5.95M 2.63% 5
2015
Q2
$37.5M Sell
479,760
-63,296
-12% -$5.09M 3.1% 5
2015
Q1
$44.5M Sell
543,056
-93,041
-15% -$8M 3.45% 5
2014
Q4
$57.9M Buy
636,097
+3,489
+0.6% +$307K 6.13% 4
2014
Q3
$53M Buy
632,608
+124,532
+25% +$10.2M 6.03% 5
2014
Q2
$39.1M Sell
508,076
-94,372
-16% -$7.61M 6.36% 3
2014
Q1
$48.6M Buy
602,448
+8,224
+1% +$648K 5.52% 6
2013
Q4
$48.4M Buy
594,224
+10,507
+2% +$856K 5.61% 6
2013
Q3
$44.1M Buy
583,717
+12,932
+2% +$1.03M 5.92% 4
2013
Q2
$43.9M Buy
+570,785
New +$44.8M 5.94% 4

Other funds holding PG

Cullinan Associates's PG Position: Q1 2026 in Review

Cullinan Associates reduced its Procter & Gamble (PG) stake by 13% in Q1 2026, selling an estimated $5.05M and leaving 225,713 shares worth $32.6M. The position accounts for 2.64% of the portfolio, ranked #8.

Cullinan Associates first reported a position in PG in Q2 2013 and has held it in 52 quarters since. The position peaked at $57.9M in Q4 2014. 3,984 funds tracked by Wall St. Rank hold PG as of Q1 2026.

  • Cullinan Associates held 225,713 shares of Procter & Gamble worth $32.6M as of Q1 2026.
  • Cullinan Associates sold 33,337 Procter & Gamble shares in Q1 2026, an estimated $5.05M.
  • Procter & Gamble made up 2.64% of Cullinan Associates's portfolio in Q1 2026, its #8 holding.
  • Cullinan Associates first reported a position in Procter & Gamble in Q2 2013 and has held it in 52 quarters since.
  • Cullinan Associates's Procter & Gamble position peaked at $57.9M in Q4 2014.
  • 3,984 funds tracked by Wall St. Rank held Procter & Gamble as of Q1 2026.

Based on Cullinan Associates's 13F filing for Q1 2026, filed 1 May 2026.